|
1
|
Stupp R, Tonn JC, Brada M and
Pentheroudakis G: High-grade malignant glioma: ESMO clinical
practice guidelines for diagnosis, treatment and follow-up. Ann
Oncol. 21:(Suppl 5). v190–v193. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schwartzbaum JA, Fisher JL, Aldape KD and
Wrensch M: Epidemiology and molecular pathology of glioma. Nat Clin
Pract Neurol. 2:494–503. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kleihues P and Ohgaki H: Primary and
secondary glioblastomas: From concept to clinical diagnosis. Neuro
Oncol. 1:44–51. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fisher JL, Schwartzbaum JA, Wrensch M and
Wiemels JL: Epidemiology of brain tumors. Neurol Clin. 25:867–890,
vii. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
McNeill KA: Epidemiology of brain tumors.
Neurol Clin. 34:981–998. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee RC, Feinbaum RL and Ambros V: The C.
Elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Reinhart BJ, Slack FJ, Basson M,
Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR and Ruvkun G:
The 21-nucleotide let-7 RNA regulates developmental timing in
Caenorhabditis elegans. Nature. 403:901–906. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cheng AM, Byrom MW, Shelton J and Ford LP:
Antisense inhibition of human miRNAs and indications for an
involvement of miRNA in cell growth and apoptosis. Nucleic Acids
Res. 33:1290–1297. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tanno B, Cesi V, Vitali R, Sesti F,
Giuffrida ML, Mancini C, Calabretta B and Raschellà G: Silencing of
endogenous IGFBP-5 by micro RNA interference affects proliferation,
apoptosis and differentiation of neuroblastoma cells. Cell Death
Differ. 12:213–223. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liang T, Guo L and Liu C: Genome-wide
analysis of mir-548 gene family reveals evolutionary and functional
implications. J Biomed Biotechnol. 2012:6795632012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rane JK, Scaravilli M, Ylipää A, Pellacani
D, Mann VM, Simms MS, Nykter M, Collins AT, Visakorpi T and
Maitland NJ: MicroRNA expression profile of primary prostate cancer
stem cells as a source of biomarkers and therapeutic targets. Eur
Urol. 67:7–10. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guo J, Miao Y, Xiao B, Huan R, Jiang Z,
Meng D and Wang Y: Differential expression of microRNA species in
human gastric cancer versus non-tumorous tissues. J Gastroenterol
Hepatol. 24:652–657. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chang H, Kim N, Park JH, Nam RH, Choi YJ,
Lee HS, Yoon H, Shin CM, Park YS, Kim JM and Lee DH: Different
microRNA expression levels in gastric cancer depending on
Helicobacter pylori infection. Gut Liver. 9:188–196. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rushton JJ, Davis LM, Lei W, Mo X, Leutz A
and Ness SA: Distinct changes in gene expression induced by A-Myb,
B-Myb and c-Myb proteins. Oncogene. 22:308–313. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rushton JJ and Ness SA: The conserved DNA
binding domain mediates similar regulatory interactions for A-Myb,
B-Myb and c-Myb transcription factors. Blood Cells Mol Dis.
27:459–463. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ramsay RG and Gonda TJ: MYB function in
normal and cancer cells. Nat Rev Cancer. 8:523–534. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou Y and Ness SA: Myb proteins: Angels
and demons in normal and transformed cells. Front Biosci (Landmark
Ed). 16:1109–1131. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ramkissoon LA, Horowitz PM, Craig JM,
Ramkissoon SH, Rich BE, Schumacher SE, McKenna A, Lawrence MS,
Bergthold G, Brastianos PK, et al: Genomic analysis of diffuse
pediatric low-grade gliomas identifies recurrent oncogenic
truncating rearrangements in the transcription factor MYBL1. Proc
Natl Acad Sci USA. 110:8188–8193. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Method. 25:402–408. 2001.
View Article : Google Scholar
|
|
22
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cho WC: OncomiRs: The discovery and
progress of microRNAs in cancers. Mol Cancer. 6:602007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dobson JR, Taipaleenmäki H, Hu YJ, Hong D,
van Wijnen AJ, Stein JL, Stein GS, Lian JB and Pratap J:
hsa-mir-30c promotes the invasive phenotype of metastatic breast
cancer cells by targeting NOV/CCN3. Cancer Cell Int. 14:732014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim BH, Hong SW, Kim A, Choi SH and Yoon
SO: Prognostic implications for high expression of oncogenic
microRNAs in advanced gastric carcinoma. J Surg Oncol. 107:505–510.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Stephens PJ, Tarpey PS, Davies H, Van Loo
P, Greenman C, Wedge DC, Nik-Zainal S, Martin S, Varela I, Bignell
GR, et al: The landscape of cancer genes and mutational processes
in breast cancer. Nature. 486:400–404. 2012.PubMed/NCBI
|
|
28
|
Fedele M, Visone R, De Martino I, Troncone
G, Palmieri D, Battista S, Ciarmiello A, Pallante P, Arra C,
Melillo RM, et al: HMGA2 induces pituitary tumorigenesis by
enhancing E2F1 activity. Cancer Cell. 9:459–471. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou YE, O'Rourke JP, Edwards JS and Ness
SA: Single molecule analysis of c-myb alternative splicing reveals
novel classifiers for precursor B-ALL. PLoS One. 6:e228802011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Brill LB II, Kanner WA, Fehr A, Andrén Y,
Moskaluk CA, Löning T, Stenman G and Frierson HF Jr: Analysis of
MYB expression and MYB-NFIB gene fusions in adenoid cystic
carcinoma and other salivary neoplasms. Mod Pathol. 24:1169–1176.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ganter B, Fu S and Lipsick JS: D-type
cyclins repress transcriptional activation by the v-Myb but not the
c-Myb DNA-binding domain. EMBO J. 17:255–268. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ameh EA, Mshelbwala PM, Nasir AA, Lukong
CS, Jabo BA, Anumah MA and Nmadu PT: Surgical site infection in
children: Prospective analysis of the burden and risk factors in a
sub-Saharan African setting. Surg Infect (Larchmt). 10:105–109.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tanno B, Sesti F, Cesi V, Bossi G,
Ferrari-Amorotti G, Bussolari R, Tirindelli D, Calabretta B and
Raschellà G: Expression of Slug is regulated by c-Myb and is
required for invasion and bone marrow homing of cancer cells of
different origin. J Biol Chem. 285:29434–29445. 2010. View Article : Google Scholar : PubMed/NCBI
|
